Femasys (FEMY) Accounts Payables (2020 - 2026)
Femasys' (FEMY) quarterly Accounts Payables came in at $1.6 million in Q1 2026, down 31.49% YoY from $2.3 million in Q1 2025, and down 12.71% on a QoQ basis from $1.8 million in Q4 2025.
Femasys (FEMY) Accounts Payables (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Accounts Payables data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Accounts Payables fell 31.49% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 31.49% YoY) and the FY2025 annual result came in at $1.8 million, up 28.97% from the prior year.
- Accounts Payables fell to $1.6 million in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $3.3 million in Q2 2025 to a low of $419110.0 in Q3 2022.
- A 5-year average of $1.2 million and a median of $1.1 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables sank 54.77% — and 2025, when it surged 242.99%.
- Tracing FEMY's Accounts Payables over 5 years: stood at $510758.0 in 2022, then jumped by 122.77% to $1.1 million in 2023, then rose by 24.72% to $1.4 million in 2024, then rose by 28.97% to $1.8 million in 2025, then decreased by 12.71% to $1.6 million in 2026.
- The last three Accounts Payables figures came in at $1.6 million (Q1 2026), $1.8 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.84 Bn | 129.62 Bn | 1.96 Bn | 277.20 Mn |
| 2 | Becton Dickinson | 52.51 Bn | 51.64 Bn | 2.32 Bn | 6.11 Bn |
| 3 | Alcon | 35.73 Bn | 34.37 Bn | 1.68 Bn | 968.00 Mn |
| 4 | Resmed | 33.92 Bn | 32.45 Bn | 861.22 Mn | 308.92 Mn |
| 5 | Medline | 29.13 Bn | 26.46 Bn | 2.22 Bn | 1.04 Bn |
| 6 | West Pharmaceutical Services | 24.89 Bn | 24.45 Bn | 329.20 Mn | 252.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 701.00 Mn |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | 233.30 Mn |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn | 1.03 Bn |
| 10 | Femasys | 9.94 Mn | 8.49 Mn | 189,391.00 | 2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 3.26 Mn |
| Mar 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 951,510.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 851,877.00 |
| Jun 30, 2023 | 546,877.00 |
| Mar 31, 2023 | 526,764.00 |
| Dec 31, 2022 | 510,758.00 |
| Sep 30, 2022 | 419,110.00 |
| Jun 30, 2022 | 428,325.00 |
| Mar 31, 2022 | 548,377.00 |
| Dec 31, 2021 | 445,522.00 |
| Sep 30, 2021 | 436,890.00 |
| Jun 30, 2021 | 947,078.00 |